CDKN2A and viral infectious disease: The meta-pathway for HPV-positive tumors is also associated with immune responses to viral infection and upregulation of cell cycle events, which has been observed along with p16 (CDKN2A) upregulation in HPV-positive tumors due to Rb deregulation caused by HPV E7 oncoprotein [33], [34].